← Back to catalogue

Integrity Bone Conductor

FDA UDI

Class II (US FDA UDI)

by Vivosonic Inc

Identity

Trade Name
Integrity Bone Conductor FDA UDI
Generic Name
Evoked-potential audiometer FDA UDI
Device Name
Bone conductor for use as an accessory with the second generation Integrity V500 system (DI: 00627908020017). The UDI is comprised of: GTIN + version/revision (VARIANT) + Date of Manufacture (PROD DATE) + Serial Number (SERIAL) FDA UDI
Model / Reference
B71W FDA UDI
Description
Bone conductor for use as an accessory with the second generation Integrity V500 system (DI: 00627908020017). The UDI is comprised of: GTIN + version/revision (VARIANT) + Date of Manufacture (PROD DATE) + Serial Number (SERIAL) FDA UDI

Identifiers

Primary DI / UDI-DI
00627908020055 FDA UDI
510(k) Number
K043396 FDA UDI
FDA Product Code
EWO FDA UDI
GWJ FDA UDI
GMDN Term
Evoked-potential audiometer FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
874.1050 FDA UDI
882.1900 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

Yes

FDA UDI

Category: Evoked-potential audiometer

Integrity Bone Conductor by Vivosonic Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Evoked-potential audiometer.

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Vivosonic Inc

Sources (1)

  • FDA UDI ae0fa52a-b852-43c8-a634-8ac4b0c9933b 34 fields · synced May 30, 2026